Pope does not need further treatment after lung cancer surgery
Test results have confirmed his diagnosis as a lung adenocarcinoma that was localised.
These trials are currently recruiting participants in the UK. Always speak to your GP or specialist before contacting a trial team.
This is a Phase 1/2A, open label, multicenter, nonrandomized, multiple dose, safety, tolerability, pharmacokinetic and pharmacodynamic study of PF-07220060 administered as a…
Researchers are looking for other ways to treat high-grade serous and certain other ovarian cancer. High-grade means the cancer cells grow and…
This is a study to evaluate the efficacy and safety of belzutifan monotherapy in participants with advanced pheochromocytoma/paraganglioma (PPGL), pancreatic neuroendocrine tumor…
The purpose of this study is to evaluate the efficacy and safety of lutetium (177Lu) vipivotide tetraxetan (AAA617) in participants with oligometastatic…
This is a Phase 1/2 open-label, multi-center, multi-national study with an initial dose escalation part to determine the recommended Phase II dose…
The goal of this clinical trial is to learn if using a liver-directed therapy with high dose chemotherapy followed by approved cancer…
Your patient insight is valuable. Take a short survey and help researchers improve treatments for Cancer.
Living with Cancer? Your experience can help others. Share what you've learned.
Thousands of UK patients are managing Cancer. Connect, share experiences, and support each other.
The latest pipeline drugs, clinical breakthroughs, and regulatory approvals from the FDA, EMA and NICE for Cancer patients.
TA1202
TA1197
๐ Information sourced from clinical trial registries, FDA, EMA and published research
View all research โNo podcasts available yet for Cancer
Sign up for updates below to be notified when we release a free patient podcast for this area.